Phibro Animal Health (NASDAQ:PAHC) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Phibro Animal Health (NASDAQ:PAHC) had its price objective hoisted by Morgan Stanley from $20.00 to $25.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

Several other analysts also recently weighed in on PAHC. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, December 6th. Bank of America increased their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Friday, August 30th. Finally, Barclays lifted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Trading Up 2.5 %

NASDAQ PAHC opened at $21.81 on Tuesday. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The stock has a market capitalization of $883.37 million, a P/E ratio of 50.72, a PEG ratio of 0.58 and a beta of 0.51. The firm’s 50-day moving average is $23.61 and its two-hundred day moving average is $20.66. Phibro Animal Health has a 12 month low of $10.03 and a 12 month high of $25.98.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.20%. Phibro Animal Health’s payout ratio is 111.63%.

Institutional Investors Weigh In On Phibro Animal Health

A number of hedge funds have recently bought and sold shares of PAHC. CWM LLC increased its stake in shares of Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after buying an additional 1,035 shares during the period. Summit Securities Group LLC purchased a new stake in shares of Phibro Animal Health in the 2nd quarter valued at approximately $83,000. Acadian Asset Management LLC raised its holdings in shares of Phibro Animal Health by 6.3% in the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after purchasing an additional 42,299 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Phibro Animal Health by 119.6% during the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after purchasing an additional 189,068 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Phibro Animal Health by 5.7% during the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after purchasing an additional 42,086 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.